Exosomes in Tumor Immunotherapy: Mediator, Drug Carrier, and Prognostic Biomarker

Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy

Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites

Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets

Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

Rewiring local immune milieu by boosting dendritic cell for pancreatic cancer treatment

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

Oncolytic Viral Therapy for Malignant Pleural Mesothelioma

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review